1242850-23-2

Upstream product

• 1361582-32-2 ethyl 2-(2-chloro-6-methylphenylsulfonyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-1-carboxylate 
• 1242850-22-1 Ethyl 1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazine-1-carboxylate 
• 1242850-17-4 ethyl 3,4-dihydropyrrolo[1,2-a]pyrazine-1-carboxylate 
• 1242850-16-3 ethyl 2-(2-(1H-pyrrol-1-yl)ethylamino)-2-oxoacetate 
• 29709-35-1 1-(2-aminoethyl)pyrrole 
• 73627-16-4 N-[2-(1H-pyrrol-1-yl)ethyl]acetamide 

Downstream Products

• 1242850-02-7 2-((2-(2-chloro-6-methylphenylsulfonyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-1-yl)methoxy)acetic acid 
• 1242850-24-3 tert-Butyl 2-((2-(2-chloro-6-methylphenylsulfonyl)-1,2,3,4-tetrahydropyrrolo[1,2-a]pyrazin-1-yl)methoxy)acetate 

Relevant academic research and scientific papers

Substituted Tetrahydropyrrolopyrazine Compounds

Tetrahydropyrrolopyrazine compounds, methods for their preparation, pharmaceutical compositions containing such compounds, and a method of using such compounds for the treatment of pain and other conditions mediated at least partially by Bradykinin 1 rece

SUBSTITUTED TETRAHYDROPYRROLOPYRAZINE DERIVATIVES

The present invention relates to tetrahydropyrrolopyrazines, methods for the preparation thereof, medicaments containing these compounds and compounds for the use of treating, amongst other things, pain.